We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Zoll Medical

Develops and markets medical devices and software solutions for advance emergency care, including products for defib... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Wearable Defibrillator Reduces Mortality after Heart Attack

By HospiMedica International staff writers
Posted on 21 Mar 2018
Print article
Image: The LifeVest WCD (Photo courtesy of Zoll Medical).
Image: The LifeVest WCD (Photo courtesy of Zoll Medical).
A defibrillator vest allows physicians time to assess and optimize medical therapy, and protects patients at risk for sudden cardiac arrest (SCA).

The Zoll Medical (Chelmsford, MA, US) LifeVest Wearable Cardioverter Defibrillator (WCD) is a lightweight vest (worn under clothing) that continuously monitors a patient’s heart with dry, non-adhesive sensing electrodes; if a life-threatening heart rhythm is detected, the device alerts the patient prior to delivering a treatment shock, allowing a conscious patient to delay treatment. If the patient becomes unconscious, the device releases a special gel over the therapy electrodes, delivering an electrical shock to restore normal rhythm.

The LifeVest WCD is prescribed for patients at risk of SCA, including those with a low ejection fraction (EJ), patients who have recently suffered a myocardial infarct (MI), those with a new diagnosis of heart failure (HF), and post-coronary revascularization patients. In a recent study that enrolled 2,302 post-MI patients in four countries, the LifeVest WCD, together with guideline directed medical therapy (GDMT) reduced total mortality by 36% in the first 90 days following MI, compared to GDMT alone. The study was presented American College of Cardiology (ACC) 67th annual scientific session, held during March 2018 in Orlando (FL, USA).

“In addition to the current best practices in medicine which includes GDMT, use of the LifeVest WCD can further reduce mortality in patients with a low EF,” said Kent Volosin, MD, vice president of medical and clinical affairs for ZOLL LifeVest. “The totality of clinical evidence supporting use of the WCD, along with guideline recommendations, underscores the need to evaluate all patients for sudden cardiac death risk and discuss WCD therapy with patients and their families through a shared decision-making approach.”

A companion online patient management system, The LifeVest Network, allows clinicians to monitor patient data downloaded from the LifeVest WCD, which can then be accessed online. The LifeVest Network also allows the physician to monitor patients efficiently and be notified of events recorded by the LifeVest device. The physician can log in and review patient information, or set up alerts and be notified when a patient has clinical information for review.

Gold Supplier
SBRT Phantom with Removable Spine
E2E SBRT Phantom with Removable Spine Model 036S-CVXX-xx
Portable Manual Defibrillator
Elevating X-Ray Table
Surgical Table

Print article



view channel
Image: MyoVista Wavelet technology utilizes AI for early detection of heart disease (Photo courtesy of Heart Test Laboratories)

Novel ECG Technology Utilizes AI for Early Detection of Heart Disease

Cardiovascular disease is responsible for 17.9 million deaths every year, or about 32% of all deaths worldwide. Every week, millions of electrocardiographs (ECGs) are performed across the world, making... Read more

Surgical Techniques

view channel
Image: The Vena BDAC provides a superior solution to distal navigation (Photo courtesy of Vena Medical)

Category-Defining Balloon Distal Access Catheter Allows Surgeons to Get Much Closer to Blood Clots

Thrombectomy is a minimally invasive procedure for removing a blood clot and has now become standard of care treatment for patients with an acute ischemic stroke (AIS) secondary to a Large Vessel Occlusion (LVO).... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more


view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.